Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2010-03-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Foveal Sparing of the ILM
NCT03488576
Foveal Sparing ILM Peeling With ILM Flap Transposition
NCT05897671
Internal Limiting Membrane Peeling for Large Macular Holes
NCT00190190
Impact of ILM Peeling in RRD/ I-Peel
NCT04767555
Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery
NCT04130841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epimacular Gliosis Without Macular Hole
No interventions assigned to this group
Epimacular Gliosis With Macular Hole
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be scheduled for ILM-peeling independently of study
* Must be older then 18 years of age
Exclusion Criteria
* Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M. Dominik Fischer
PD Dr. med. M. Dominik Fischer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florian Gekeler, MD
Role: PRINCIPAL_INVESTIGATOR
Centre for Ophthalmology, University Hospital Tuebingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Ophthalmology, University Hospital Tuebingen
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILM Peeling
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.